Trading Signals: FOLD Stock Price Prediction and Forecast (Thu. May. 31, 2007 - Fri. Dec. 22, 2023)(Amicus Therapeutics Inc)
| FOLD latest price $12.0600 (6.26%) ($11.4500 - $12.1800) on Mon. Jun. 17, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.93% (three month average) | RSI | 51 | Latest Price | $12.0600(6.26%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | FOLD advances 1.1% a day on average for past five trading days. | Weekly Trend | FOLD declines -0.1% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Rotation from value to growth for small cap. | Correlated ETFs | Broad market will support FOLD advance at 0% a week (0% probability) IBB(60%) XBI(57%) IWO(55%) IWM(52%) IWC(50%) | Factors Impacting FOLD price | FOLD will decline at least -1.465% in a week (0% probabilities). VXX(-19%) TLT(-14%) IFRA(-9%) TIP(-1%) UNG(-0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.465% (StdDev 2.93%) | Hourly BBV | 0 () | Intraday Trend | 4.3% | | | |
|
1 - 5 Day Possible Target | $5.11(-57.63%) | 5 Day Moving Average | $11.52(4.69%) | 10 Day Moving Average | $11.7(3.08%) | 20 Day Moving Average | $11.73(2.81%) | To recent high | -16.3% | To recent low | 10% | Market Cap | $3.114b | | | | Amicus Therapeutics, Inc. is a biotechnology company focused on discovering, developing, and delivering medicines for people living with rare metabolic diseases. The company is committed to advancing and expanding a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. Amicus Therapeutics has a portfolio of product opportunities including the first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants; a novel, clinical-stage, treatment paradigm for Pompe disease; and a rare disease gene therapy portfolio. The company was founded on February 4, 2002 and is headquartered in Cranbury, NJ. |